To address the paucity of HIV-related lymphoma (HRL)–specific prognostic scores for the Japanese population by analyzing domestic cases of HRL and constructing a predictive model.A single-center retrospective study coupled with a review of case …
EHA Library; Johnson P. Jun 14 2025; 4160972;
With a growing number of treatment options for blood cancers, understanding the side effects from these treatments and how they affect patients is becoming ever…
A variety of factors influence a patient’s clinical outcome, including intrinsic characteristics of the patient, disease, or medical condition, and the effects of any treatments…
Leukemia – Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?
ACCORDS hosts several works in progress groups to facilitate meeting and collaboration around these specific topic areas in health services research. ACCORDS provides meeting space…
Thrombotic microangiopathy (TMA) is a clinical syndrome characterized by endothelial injury and thrombotic occlusion of the microvasculature, leading to end-organ damage. This systemic disorder can affect…
NCBI’s Gene Expression Omnibus (GEO) is a public archive and resource for gene expression data.
Venetoclax showed promising activity in a small phase II trial in relapsed/refractory Waldenström macroglobulinemia (WM). To report the clinical activity of venetoclax and prognostic factors…
Key PointsIbrutinib and nivolumab showed a response rate of 78% and the best complete response rate was 50% for relapsed/refractory CNS lymphomas.
Key Points. Acalabrutinib-obinutuzumab results in significantly higher PFS and OS vs chemoimmunotherapy regardless of high-risk features in TN CLLAcalabrut
